Craft

Advanced
Biolidics

Biolidics

Stock Price

$0

2024-10-29

Market Capitalization

$6.7 M

2024-10-29

Revenue

$5.3 M

FY, 2025

Biolidics Summary

Company Summary

Overview
Biolidics is a medical technology company focusing on the development of cell enrichment systems. It offers the ClearCell FX1 system, an automated IVD medical device aiming to separate and enrich cancer cells from blood.
Type
Public
Status
Active
Founded
2009
Website
https://www.biolidics.com/
Cybersecurity rating
Sectors

Table of Contents

Key People

  • Jeremy Yee, Non-Executive Non-Independent Chairman

    • Leong Man Chun, Interim Chief Executive Officer

      • Johnson Chen, Non-Executive Non-Independent Director and Founder

        • Leong Yow Seng, Lead Independent Director

          Biolidics Financials

          Summary Financials

          Revenue (FY, 2025)
          $S5.3M
          Gross profit (FY, 2025)
          $S2.0M
          Net income (FY, 2025)
          ($S4.0M)
          Cash (FY, 2025)
          $S557.0K
          EBIT (FY, 2025)
          ($S3.9M)
          Enterprise value
          $8.6M

          Competitors and Similar Companies

          Compare competitors

          Footer menu

          Product

          Solutions

          Resources

          Company

          © Craft.co 2026
          Share price data provided by IEX